DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Keliximab
Keliximab
The Two Tontti Tudiul Lui Hi Ha Unit
A Human CD4 Monoclonal Antibody for the Treatment of T-Cell
(INN) for Biological and Biotechnological Substances
INN Working Document 05.179 Update 2011
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
Customs Tariff - Schedule
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
Providing for Duty-Free Treatment for Specified Pharmaceutical Active
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
Patent No.: US 8877913 B2
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
A1091-Anti-CD4 (Clenoliximab)
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Wo 2010/095940 A2
Top View
Official Journal L 175
Role of Biologics in the Management of Asthma
'Prospective New Biological Therapies for Rheumatoid Arthritis'
Pharmaabkommen A1 E
Anti-CD4 [CE9.1 (Clenoliximab)] Bulk Size Ab00450-13.0-BT
Single-Chain Variable Fragment
Customs Tariff - Schedule Xxi - 1
Anti-CD4 [CE9.1 (Clenoliximab)] Standard Size Ab00450-1.1
WO 2012/160186 Al 29 November 2012 (29.11.2012) P O P C T
Therapy with Anti-Cd4 Antibodies and Radiation Therapie Mit Anti-Cd4-Antikörpern Und Bestrahlung Traitement Au Moyen D’Anticorps Anti-Cd4 Et Par Rayonnements
(12) United States Patent (10) Patent No.: US 9,309,315 B2
Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
Monoclonal Antibody to Human CD4 Effector Functions of a Modified
Immunomodulatory Treatment for the Intractable Paediatric Epilepsies Luis E
(INN) for Biological and Biotechnological Substances
Antibodies[Version 1; Peer Review: 2 Approved]
Thalidomide - Wikipedia, the Free Encyclopedia
Assessment of the Evolution of Cancer Treatment Therapies
Federal Register/Vol. 64, No. 13/Thursday, January 21, 1999/Notices